Toomas Talme

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Pyoderma gangrenosum with plasma cell dyscrasia should be subject for anti-myeloma treatment.

Pyoderma gangrenosum with plasma cell dyscrasia should be subject for anti-myeloma treatment.

Journal: International journal of dermatology

Published: February 02, 2021

Low-dose methotrexate use and safety for older patients with bullous pemphigoid and impaired renal function: A cohort study.

Low-dose methotrexate use and safety for older patients with bullous pemphigoid and impaired renal function: A cohort study.

Journal: Journal of the American Academy of Dermatology

Published: March 19, 2019

Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study.

Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: December 14, 2017

European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC.

European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 28, 2017

Transient Elastography May Improve Detection of Liver Fibrosis in Psoriasis Patients Treated with Methotrexate.

Transient Elastography May Improve Detection of Liver Fibrosis in Psoriasis Patients Treated with Methotrexate.

Journal: Acta dermato-venereologica

Published: April 20, 2017

Methotrexate and its therapeutic antagonists caffeine and theophylline, target a motogenic T-cell mechanism driven by thrombospondin-1 (TSP-1).

Methotrexate and its therapeutic antagonists caffeine and theophylline, target a motogenic T-cell mechanism driven by thrombospondin-1 (TSP-1).

Journal: European journal of immunology

Published: October 13, 2015

European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC.

European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 22, 2015

Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors.

Antigen-induced regulation of T-cell motility, interaction with antigen-presenting cells and activation through endogenous thrombospondin-1 and its receptors.

Journal: Immunology

Published: June 25, 2014

Regulation of T-lymphocyte motility, adhesion and de-adhesion by a cell surface mechanism directed by low density lipoprotein receptor-related protein 1 and endogenous thrombospondin-1.

Regulation of T-lymphocyte motility, adhesion and de-adhesion by a cell surface mechanism directed by low density lipoprotein receptor-related protein 1 and endogenous thrombospondin-1.

Journal: Immunology

Published: May 31, 2014

Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis.

Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: March 11, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026